Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03341247 · ClinicalTrials.gov registry record
Brain Mechanisms of Overeating in Children
A clinical trial, sponsored by Penn State University.
- Completed
- Registry status
- 254
- Enrollment target
NCT03341247: Completed study, sponsored by Penn State University.
NCT03341247 is a clinical trial that has completed, run by Penn State University. The registered enrollment target is 254 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03341247 has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- 254 participants
- Enrollment target
Study Summary
The proposed research will follow healthy weight children who vary by family risk for obesity to identify the neurobiological and appetitive traits that are implicated in overeating and weight gain during the critical pre-adolescent period. The investigator's central hypothesis is that increased intake from large portions of energy dense foods is due in part to reduced activity in brain regions implicated in inhibitory control and decision making, combined with increased activity in reward processing pathways. To test this hypothesis, the investigators will recruit 120 healthy weight children, aged 7-8 years, at two levels of obesity risk (i.e., 60 high-risk and 60 low-risk) based on parent weight status. This will result in 240 participants: 120 children and their parents.
Primary Outcome
The investigators will use functional magnetic resonance imaging to characterize the brain regions which are activated in response to food portion size and compare these regions between high- and low-risk children.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2018-01-31 |
| Est. Completion | 2023-06-20 |
What the finished NCT03341247 record still lists
NCT03341247 is an observational study that tracks outcomes without assigning an intervention. The registered 254 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03341247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03341247 about?
NCT03341247 is a clinical study titled "Brain Mechanisms of Overeating in Children". The proposed research will follow healthy weight children who vary by family risk for obesity to identify the neurobiological and appetitive traits that are implicated in overeating and weight gain during the critical pre-adolescent period. The investigator's central hypothesis is that increased int...
What is the current status of trial NCT03341247?
This trial is currently completed. The enrollment target is 254 participants. The study started on 2018-01-31. Estimated completion is 2023-06-20.
Who is sponsoring clinical trial NCT03341247?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI